5-Amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester, 99.0%, 250mg

2-tert-butylpyrimidine-5-carbaldehyde, 95.0%, 250mg

(4-Methoxy-3,5-dimethylpyridin-2-yl)methanol, 97.0%, 10g

N-(3-hydroxypropyl)acetamide, 95.0%, 25g

Dasatinib, 95.0%, 10g

4-Methyl-3-oxo-pentanoic acid ethyl ester, 95.0%, 10g

1H,1H,7H-Dodecafluoroheptyl methacrylate, 95.0%, 5g

3-(2-Methoxyphenyl)-1-propene, 97.0%, 25g

1,3-Diallyl-5-propyl-1,3,5-triazinane-2,4,6-trione, 95% (stabilized with BHT), 5g

(S)-2-Methylmorpholine hydrochloride, 95.0%, 250mg

3-Iodo-6-nitroindazole>98.0%(GC)5g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 750m2/g)25g

6-Bromoimidazo[1,2-a]pyrazine-8-carboxylic acid, 97%, 100mg